APOBEC3B and breast carcinoma: Analysis of breast cancers from The Cancer Genome Atlas (TCGA) showed that germline APOBEC3B deletion is associated with an OR of 2.68 for one-copy deletion, and an OR of 3.82 for two-copy deletion with tumours that have a hypermutator phenotype [9].